» Articles » PMID: 34552498

Detecting Pathogen Exposure During the Non-symptomatic Incubation Period Using Physiological Data: Proof of Concept in Non-human Primates

Abstract

Early warning of bacterial and viral infection, prior to the development of overt clinical symptoms, allows not only for improved patient care and outcomes but also enables faster implementation of public health measures (patient isolation and contact tracing). Our primary objectives in this effort are 3-fold. , we seek to determine the upper limits of early warning detection through physiological measurements. , we investigate whether the detected physiological response is specific to the pathogen. , we explore the feasibility of extending early warning detection with wearable devices. For the first objective, we developed a supervised random forest algorithm to detect pathogen exposure in the asymptomatic period prior to overt symptoms (fever). We used high-resolution physiological telemetry data (aortic blood pressure, intrathoracic pressure, electrocardiograms, and core temperature) from non-human primate animal models exposed to two viral pathogens: Ebola and Marburg ( = 20). Second, to determine reusability across different pathogens, we evaluated our algorithm against three independent physiological datasets from non-human primate models ( = 13) exposed to three different pathogens: Lassa and Nipah viruses and . For the third objective, we evaluated performance degradation when the algorithm was restricted to features derived from electrocardiogram (ECG) waveforms to emulate data from a non-invasive wearable device. First, our cross-validated random forest classifier provides a mean early warning of 51 ± 12 h, with an area under the receiver-operating characteristic curve (AUC) of 0.93 ± 0.01. Second, our algorithm achieved comparable performance when applied to datasets from different pathogen exposures - a mean early warning of 51 ± 14 h and AUC of 0.95 ± 0.01. Last, with a degraded feature set derived solely from ECG, we observed minimal degradation - a mean early warning of 46 ± 14 h and AUC of 0.91 ± 0.001. Under controlled experimental conditions, physiological measurements can provide over 2 days of early warning with high AUC. Deviations in physiological signals following exposure to a pathogen are due to the underlying host's immunological response and are not specific to the pathogen. Pre-symptomatic detection is strong even when features are limited to ECG-derivatives, suggesting that this approach may translate to non-invasive wearable devices.

Citing Articles

Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.

Mason A, Hecht F, Davis S, Natale J, Hartogensis W, Damaso N Sci Rep. 2022; 12(1):3463.

PMID: 35236896 PMC: 8891385. DOI: 10.1038/s41598-022-07314-0.


A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data.

Gladding P, Ayar Z, Smith K, Patel P, Pearce J, Puwakdandawa S Future Sci OA. 2021; 7(7):FSO733.

PMID: 34254032 PMC: 8204819. DOI: 10.2144/fsoa-2020-0207.


Personalized Analytics and a Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation (DeCODe): Protocol for the Development of the COVID-19 Decompensation Index.

Larimer K, Wegerich S, Splan J, Chestek D, Prendergast H, Hoek T JMIR Res Protoc. 2021; 10(5):e27271.

PMID: 33949966 PMC: 8158529. DOI: 10.2196/27271.

References
1.
Fraser C, Riley S, Anderson R, Ferguson N . Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A. 2004; 101(16):6146-51. PMC: 395937. DOI: 10.1073/pnas.0307506101. View

2.
Chen W, Kuo C . Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med. 2007; 14(5):392-7. DOI: 10.1197/j.aem.2006.12.015. View

3.
Beishuizen A, Thijs L . Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res. 2003; 9(1):3-24. DOI: 10.1179/096805103125001298. View

4.
Sedlak R, Jerome K . Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis. 2012; 75(1):1-4. PMC: 3519953. DOI: 10.1016/j.diagmicrobio.2012.10.009. View

5.
Laupland K . Fever in the critically ill medical patient. Crit Care Med. 2009; 37(7 Suppl):S273-8. DOI: 10.1097/CCM.0b013e3181aa6117. View